Literature DB >> 7991260

Technique for injection of botulinum toxin through the flexible nasolaryngoscope.

K Rhew1, D A Fiedler, C L Ludlow.   

Abstract

A new endoscopic method of injecting botulinum toxin into the thyroarytenoid muscles for treatment of adductor spasmodic dysphonia was evaluated. Twelve patients with adductor spasmodic dysphonia were given injections in the thyroarytenoid muscle under video visualization with a flexible catheter needle that was passed through the working channel of a flexible nasolaryngoscope. Six patients received unilateral injections, and six received bilateral injections. Preinjection and postinjection speech samples were compared by use of spectrographic analysis. Significant decreases in voice breaks and sentence duration were found after treatment with both unilateral and bilateral injections. Patient interviews and diaries documented the reported degree and duration of symptom reduction. All 12 patients reported that the injections were of significant benefit and that the endoscopic procedure was tolerable. We concluded that this is a safe and effective technique for injecting botulinium toxin into laryngeal muscles for treatment of spasmodic dysphonia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7991260     DOI: 10.1177/019459989411100615

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  10 in total

Review 1.  Use of botulinum toxin in the neurology clinic.

Authors:  Erle C H Lim; Raymond C S Seet
Journal:  Nat Rev Neurol       Date:  2010-10-12       Impact factor: 42.937

2.  The consequences of spasmodic dysphonia on communication-related quality of life: a qualitative study of the insider's experiences.

Authors:  Carolyn R Baylor; Kathryn M Yorkston; Tanya L Eadie
Journal:  J Commun Disord       Date:  2005 Sep-Oct       Impact factor: 2.288

Review 3.  [The treatment of laryngeal movement disorders with botulinum toxin: part 2: experience and considerations].

Authors:  C Schwemmle; M Ptok
Journal:  HNO       Date:  2007-06       Impact factor: 1.284

Review 4.  [Treatment of laryngeal movement disorders with botulinum toxins: part 1: History and mode of action].

Authors:  C Schwemmle; M Ptok
Journal:  HNO       Date:  2007-05       Impact factor: 1.284

Review 5.  Evidence for the effectiveness of botulinum toxin for spasmodic dysphonia from high-quality research designs.

Authors:  C R Watts; D D Truong; C Nye
Journal:  J Neural Transm (Vienna)       Date:  2007-06-14       Impact factor: 3.575

Review 6.  Recommendations of the Neurolaryngology Study Group on laryngeal electromyography.

Authors:  Andrew Blitzer; Roger L Crumley; Seth H Dailey; Charles N Ford; Mary Kay Floeter; Allen D Hillel; Henry T Hoffmann; Christy L Ludlow; Albert Merati; Michael C Munin; Lawrence R Robinson; Clark Rosen; Keith G Saxon; Lucian Sulica; Susan L Thibeault; Ingo Titze; Peak Woo; Gayle E Woodson
Journal:  Otolaryngol Head Neck Surg       Date:  2009-04-09       Impact factor: 3.497

Review 7.  Chemodenervation of the Larynx.

Authors:  Rachel Kaye; Andrew Blitzer
Journal:  Toxins (Basel)       Date:  2017-11-02       Impact factor: 4.546

Review 8.  Botulinum toxin injections for the treatment of spasmodic dysphonia.

Authors:  C C W Watts; R Whurr; C Nye
Journal:  Cochrane Database Syst Rev       Date:  2004

Review 9.  Vocal aging and adductor spasmodic dysphonia: response to botulinum toxin injection.

Authors:  Michael P Cannito; Joel C Kahane; Lesya Chorna
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

10.  Transnasal Flexible Fiberoptic in-office Laryngeal Biopsies-Our Experience with 117 Patients with Suspicious Lesions.

Authors:  Jacob T Cohen; Limor Benyamini
Journal:  Rambam Maimonides Med J       Date:  2014-04-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.